Ulcerative Colitis as the Rarer Phenotype of Inflammatory Bowel Disease to Coexist with Psoriatic Arthritis: A Case Report
Keywords:
inflammatory bowel disease, ulcerative colitis, psoriasis, psoriatic arthritisAbstract
Psoriatic arthritis (PsA) has been linked to various diseases associated with immune dysregulation, such as Inflammatory Bowel Disease (IBD). Numerous studies have shown strong correlation between PsA and one of the phenotypes of IBD, Crohn’s disease. On the other hand, the studies regarding the association of PsA with ulcerative colitis (UC) are less robust and have conflicting findings. We herein report a case of 56-year-old woman with a history of psoriatic arthritis, who developed chronic diarrhea and significant weight loss. The colonoscopy and histopathologic findings were suggestive of pancolitis with backwash ileitis, from which the working diagnosis of ulcerative colitis was carried out. The patient fit the typical epidemiological profile of a PsA patient with concomitant UC, but some aspects of the clinical features observed in this case, such as the development of anterior uveitis was rarely documented in similar studies. A conducted bidirectional meta-analysis also showed that there were more cases where UC preceded the diagnosis of psoriasis, which makes the late development of UC in this case atypical. Due to the uncommon nature of the concurrent development of these two disease entities in this case, this study could provide additional insights to the association of PsA and UC.References
Affandi AM, Khan I, Saaya NN. Epidemiology and clinical features of adult patients with psoriasis in Malaysia: 10-year review from the Malaysian psoriasis registry (2007-2016). Dermatol Res Pract [Internet]. 2018 Apr 23 [cited 2020 Dec 19];2018. Available from: /pmc/articles/PMC5937568/?report=abstract
Mehrmal S, Uppal P, Nedley N, Giesey RL, Delost GR. The global, regional, and national burden of psoriasis in 195 countries and territories, 1990 to 2017: A systematic analysis from the Global Burden of Disease Study 2017. J Am Acad Dermatol. 2021;84(1):46–52.
Kim WB, Jerome D, Yeung J. Diagnosis and management of psoriasis [Internet]. Vol. 63. Canadian family physician. College of Family Physicians of Canada; 2017 [cited 2020 Dec 16]. p. 278. Available from: www.cfp.ca
Ritchlin CT, Colbert RA, Gladman DD. Psoriatic arthritis. In: Longo DL, editor. N Engl J Med [Internet]. 2017 Mar 9 [cited 2020 Dec 9];376(10):957–70. Available from: http://www.nejm.org/doi/10.1056/NEJMra1505557
Gottlieb AB, Merola JF. Axial psoriatic arthritis: An update for dermatologists [Internet]. Vol. 84. Journal of the American Academy of Dermatology. Mosby Inc.; 2020 [cited 2020 Dec 9]. p. 92–101. Available from: https://doi.org/10.1016/j.jaad.2020.05.089
Coates LC, Helliwell PS. Psoriatic arthritis: State of the art review [Internet]. Clinical medicine. Royal College of Physicians. 2017;17:65-70 [cited 2020 Dec 9]. Available from: /pmc/articles/PMC6297592/?report=abstract
Lloyd P, Ryan C, Menter A. Psoriatic arthritis: An update. Arthritis [Internet]. 2012;2012:1–6 [cited 2021 Jan 18]. Available from: https://www.hindawi.com/journals/arthritis/2012/176298/
Busse K, Liao W. Which psoriasis patients develop psoriatic arthritis? Psoriasis Forum [Internet]. 2010;16a(4):17–25 [cited 2020 Dec 19]. Available from: /pmc/articles/PMC4206220/?report=abstract
Veale DJ, Fearon U. The pathogenesis of psoriatic arthritis [Internet]. The Lancet. 2018;391:2273–84 [cited 2021 Jan 18]. Available from: http://www.thelancet.com/article/S0140673618308304/fulltext
Cather JC, Young M, Jan Bergman M. Psoriasis and psoriatic arthritis [Internet]. Matrix Medical Communications. 2017;10:S16–S25 [cited 2020 Dec 9]. Available from: /pmc/articles/PMC5367866/?report=abstract
Day MS, Nam D, Goodman S, Su EP, Figgie M. Psoriatic arthritis. Am Acad Orthop Surg [Internet]. 2012;20(1):28–37 [cited 2021 Jan 18]. Available from: http://journals.lww.com/00124635-201201000-00004
Fakhoury M, Negrulj R, Mooranian A, Al-Salami H. Inflammatory bowel disease: Clinical aspects and treatments [Internet]. Journal of Inflammation Research. 2014;7:113–20 [cited 2020 Dec 26]. Available from: /pmc/articles/PMC4106026/?report=abstract
Qin X. Why is damage limited to the mucosa in ulcerative colitis but transmural in Crohn’s disease? World J Gastrointest Pathophysiol [Internet]. 2013;4(3):63 [cited 2021 Jan 10]. Available from: /pmc/articles/PMC3740262/?report=abstract
Zhang YZ, Li YY. Inflammatory bowel disease: Pathogenesis. World J Gastroenterol [Internet]. 2014;20(1):91–9 [cited 2020 Dec 25]. Available from: /pmc/articles/PMC3886036/?report=abstract
Takeshita J, Grewal S, Langan M, et al. Psoriasis and comorbid diseases Epidemiology. 2017 [cited 2021 Jan 17]; Available from: http://dx.doi.org/10.1016/j.jaad.2016.07.064
Li W, Chan AT, Han J-L, Qureshi AA. Psoriasis, psoriatic arthritis and increased risk of incident Crohn’s disease in US women | Request PDF. Ann Rheum Dis [Internet]. 2012;72(7) [cited 2021 Jan 17]. Available from: https://www.researchgate.net/publication/230783788_Psoriasis_psoriatic_arthritis_and_increased_risk_of_incident_Crohn’s_disease_in_US_women
Skroza N, Proietti I, Pampena R, et al. Correlations between psoriasis and inflammatory bowel diseases [Internet]. BioMed Research International. 2013;2013 [cited 2020 Dec 16]. Available from: /pmc/articles/PMC3736484/?report=abstract
Fragoulis GE, Liava C, Daoussis D, Akriviadis E, Garyfallos A, Dimitroulas T. Inflammatory bowel diseases and spondyloarthropathies: From pathogenesis to treatment. World J Gastroenterol [Internet]. 2019;25(18):2162–76 [cited 2021 Jan 17]. Available from: /pmc/articles/PMC6526158/?report=abstract
Eppinga H, Poortinga S, Thio HB, et al. Prevalence and Phenotype of Concurrent Psoriasis and Inflammatory Bowel Disease. Inflamm Bowel Dis [Internet]. 2017;23(10):1783–9 [cited 2021 Jan 18]. Available from: https://pubmed.ncbi.nlm.nih.gov/28617755/
Lolli E, Saraceno R, Calabrese E, et al. Psoriasis phenotype in inflammatory bowel disease: A case-control prospective study. J Crohns Colitis [Internet]. 2015;9(9):699–707 [cited 2020 Dec 17]. Available from: https://pubmed.ncbi.nlm.nih.gov/25908719/
Charlton R, Green A, Shaddick G, et al. Risk of uveitis and inflammatory bowel disease in people with psoriatic arthritis: A population-based cohort study. Ann Rheum Dis [Internet]. 2018;77(2):277–80 [cited 2021 Jan 23]. Available from: https://pubmed.ncbi.nlm.nih.gov/29092855/
Sobolewski P, Walecka I, Dopytalska K. Nail involvement in psoriatic arthritis [Internet]. Reumatologia. 2017;55:131–5 [cited 2021 Jan 22]. Available from: /pmc/articles/PMC5534507/?report=abstract
Alinaghi F, Tekin HG, Burisch J, Wu JJ, Thyssen JP, Egeberg A. Global prevalence and bidirectional association between psoriasis and inflammatory bowel disease—A systematic review and meta-analysis. J Crohn’s Colitis [Internet]. 2020;14(3):351–60 [cited 2020 Dec 21]. Available from: https://academic.oup.com/ecco-jcc/article/14/3/351/5556860
Cottone M, Sapienza C, Macaluso FS, Cannizzaro M. Psoriasis and inflammatory bowel disease. Dig Dis [Internet]. 2019;37(6):451–7 [cited 2020 Dec 15]. Available from: https://www.karger.com/Article/FullText/500116
Scarpa Raffaele, Manguso Francesco, D’Arienzo Agesilao, D’Armiento Francesco Paolo. Microscopic inflammatory changes in colon of patients with both active psoriasis and psoriatic arthritis without bowel symptoms | Request PDF. J Rheumatol [Internet]. 2000;27(5):1241–6 [cited 2021 Jan 17]. Available from: https://www.researchgate.net/publication/12505183_Microscopic_inflammatory_changes_in_colon_of_patients_with_both_active_psoriasis_and_psoriatic_arthritis_without_bowel_symptoms
Geijer M, Lindqvist U, Husmark T, et al. The Swedish early psoriatic arthritis registry 5-year followup: Substantial radiographic progression mainly in men with high disease activity and development of dactylitis. J Rheumatol [Internet]. 2015;42(11):2110–7 [cited 2021 Jan 18]. Available from: https://pubmed.ncbi.nlm.nih.gov/26472410/
Haddad A, Zisman D. Comorbidities in patients with psoriatic arthritis. Rambam Maimonides Med J [Internet]. 2017;8(1):e0004 [cited 2020 Dec 16]. Available from: /pmc/articles/PMC5298365/?report=abstract
Mikhaylov D, Hashim PW, Nektalova T, Goldenberg G. Systemic psoriasis therapies and comorbid disease in patients with psoriasis: A review of potential risks and benefits [Internet]. Journal of Clinical and Aesthetic Dermatology. 2019;12:46–54 [cited 2021 Jan 18]. Available from: /pmc/articles/PMC6624011/?report=abstract
Ham M, Moss AC. Mesalamine in the treatment and maintenance of remission of ulcerative colitis [Internet]. Expert Review of Clinical Pharmacology. 2012;5:113–23 [cited 2021 Jan 24]. Available from: /pmc/articles/PMC3314328/?report=abstract
Kang EJ, Kavanaugh A. Psoriatic arthritis: latest treatments and their place in therapy. Ther Adv Chronic Dis [Internet]. 2015;6(4):194 [cited 2021 Jan 24]. Available from: /pmc/articles/PMC4480547/?report=abstract
Conforti C, Dianzani C, Zalaudek I, et al. Spotlight on the treatment armamentarium of concomitant psoriasis and inflammatory bowel disease: a systematic review [Internet]. Journal of Dermatological Treatment. 2020 [cited 2021 Jan 18]. Available from: https://pubmed.ncbi.nlm.nih.gov/33074781/
Downloads
Published
How to Cite
Issue
Section
License
Copyright
The authors who publish in this journal agree to the following requirements:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. (See The Effect of Open Access)
Privacy Statement
The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.
